BACKGROUND Fontan-associated liver disease is an increasing concern. Our aim was to assess prevalence and predictors of advanced liver fibrosis with a specific focus on utility of liver stiffness measurement by ultrasound transient elastography. METHODS 97 adult Fontan-patients (55% males, median age: 23.1 years, IQR: 18.7-30.6), 92 (95%) were evaluated with transient elastography and 50 (52%) underwent transjugular liver biopsy. Advanced liver fibrosis was defined as congestive hepatic fibrosis score 3 or 4. RESULTS Only four patients (4%) had liver stiffness values <10kPa. Liver stiffness measurements correlated weakly with peak oxygen uptake on exercise testing and Fontan-pressure but not with Model for End-stage Liver Dis...
About 30% of patients with Cystic Fibrosis (CF) develop CF-associated liver disease (CFLD). Recent s...
Objective: Transient elastography (TE) is gaining popularity as a non-invasive method for predicting...
Background & Aims Patients with advanced fibrosis related to nonalcoholic fatty liver disease (...
BACKGROUND Fontan-associated liver disease is an increasing concern. Our aim was to assess preval...
BACKGROUND Fontan-associated liver disease is an increasing concern. Our aim was to assess preval...
ObjectiveStudies have shown that patients with failing Fontan circulation may develop liver cirrhosi...
Objectives: Patients with Fontan circulation exhibit a high incidence of liver fibrosis and cirrhosi...
Background. Hepatic fibrosis is a potential complication following Fontan surgery and heralds long-t...
Fontan-associated liver disease (FALD) is an arising clinical entity that can occur long after a suc...
A hemodynamic derangement in Fontan circulation causes liver pathology known as Fontan‑associated li...
Liver stiffness measurement (LSM) by transient elastography (TE, FibroScan) is a validated method fo...
We tried to identify structural and functional liver aberrances in a palliated Fontan population and...
Patients with advanced fibrosis related to nonalcoholic fatty liver disease (NAFLD) are at risk of d...
[Background & Aims] Patients with advanced fibrosis related to nonalcoholic fatty liver disease (NAF...
About 30% of patients with Cystic Fibrosis (CF) develop CF-associated liver disease (CFLD). Recent s...
About 30% of patients with Cystic Fibrosis (CF) develop CF-associated liver disease (CFLD). Recent s...
Objective: Transient elastography (TE) is gaining popularity as a non-invasive method for predicting...
Background & Aims Patients with advanced fibrosis related to nonalcoholic fatty liver disease (...
BACKGROUND Fontan-associated liver disease is an increasing concern. Our aim was to assess preval...
BACKGROUND Fontan-associated liver disease is an increasing concern. Our aim was to assess preval...
ObjectiveStudies have shown that patients with failing Fontan circulation may develop liver cirrhosi...
Objectives: Patients with Fontan circulation exhibit a high incidence of liver fibrosis and cirrhosi...
Background. Hepatic fibrosis is a potential complication following Fontan surgery and heralds long-t...
Fontan-associated liver disease (FALD) is an arising clinical entity that can occur long after a suc...
A hemodynamic derangement in Fontan circulation causes liver pathology known as Fontan‑associated li...
Liver stiffness measurement (LSM) by transient elastography (TE, FibroScan) is a validated method fo...
We tried to identify structural and functional liver aberrances in a palliated Fontan population and...
Patients with advanced fibrosis related to nonalcoholic fatty liver disease (NAFLD) are at risk of d...
[Background & Aims] Patients with advanced fibrosis related to nonalcoholic fatty liver disease (NAF...
About 30% of patients with Cystic Fibrosis (CF) develop CF-associated liver disease (CFLD). Recent s...
About 30% of patients with Cystic Fibrosis (CF) develop CF-associated liver disease (CFLD). Recent s...
Objective: Transient elastography (TE) is gaining popularity as a non-invasive method for predicting...
Background & Aims Patients with advanced fibrosis related to nonalcoholic fatty liver disease (...